China (Mainland)
Premiumsupplier
- Product Details
Keywords
- AP26113
- Brigatinib
- CAS 1197958-12-5
Quick Details
- ProName: Brigatinib AP26113
- CasNo: 1197958-12-5
- Molecular Formula: C27H36ClN6O4P
- Appearance: white powder
- Application: AP26113 (also known as Brigatinib) is ...
- DeliveryTime: Within7-10 days after receipt of your ...
- PackAge: As customer request
- Port: Qingdao,China
- ProductionCapacity: 100 Kilogram/Week
- Purity: 99%
- Storage: room temp
- Transportation: By Sea/Air/Courier
- LimitNum: 10 Gram
Superiority
Lorcaserin(856681-05-5)is an orally administered agent and a selective 5-HT2C receptor agonist for the treatment of obesity. It had been approved for marketing in US by FDA on 27 June in 2012. In clinical studies, lorcaserin has demonstrated efficacy in obese and overweight populations by promoting weight loss and improving metabolic parameters, and it is well tolerated.
Details
AP26113
| CAS: | 1197958-12-5 |
| MF: | C27H36ClN6O4P |
| MW: | 575.039301 |
| Appearance: | White solid |
| Assay: | 99% |
| Boiling point: | 737.6±70.0 °C(Predicted) |
| desnity: | 1.29±0.1 g/cm3(Predicted) |
| Uses: AP26113 (also known as Brigatinib) is an investigated small molecule for targeted cancer therapy. It is a potent dual inhibitor of anaplastic lymphoma kinase (ALK) and epidermal growth factor receptor (EGFR). It is mainly under investigation for its treatmentefficacy on non-small cell lung cancer (NSCLC) where ALK is activated and EGFP mutations frequently occur. | |
